NAC-HCPS

non-anticoagulant heparin-carrying polystyrene (NAC-HCPS) affects angiogenesis and inhibits subcutaneous induced tumour growth and metastasis to the lung

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Fujita, Masanori: 1 article (01/2004)
2.	Ishihara, Masayuki: 1 article (01/2004)
3.	Kikuchi, Makoto: 1 article (01/2004)
4.	Maehara, Tadaaki: 1 article (01/2004)
5.	Matsumura, Koji: 1 article (01/2004)
6.	Morimoto, Yuji: 1 article (01/2004)
7.	Ono, Katsuaki: 1 article (01/2004)
8.	Ozaki, Shigeyuki: 1 article (01/2004)
9.	Saito, Yoshio: 1 article (01/2004)
10.	Shimizu, Masafumi: 1 article (01/2004)

Related Diseases

1.	Vascular System Injuries 01/01/2004 - "On the other hand, neointimal growth (intimal cross-section area and intimal cross-section area/medial cross-section area ratio) in vivo following vascular injury 28 days after balloon denudation in a rat carotid artery was substantially inhibited with high dose of intravenous administration (total 30 mg) of respectively IO4-Hep, IO4-LMW-Hep, and NAC-HCPS. "
2.	Neoplasm Metastasis (Metastasis) 06/05/2002 - "Periodate-treated, non-anticoagulant heparin-carrying polystyrene (NAC-HCPS) affects angiogenesis and inhibits subcutaneous induced tumour growth and metastasis to the lung."

Related Drugs and Biologics

1.	Polystyrenes (Polystyrene)
2.	Heparin (Liquaemin)
3.	Anticoagulants
4.	metaperiodate (periodate)

Related Therapies and Procedures

1.	Intravenous Administration